PTC Therapeutics CEO Matthew B. Klein sells $917,153 in stock

Markets Investing.com By Investing.com 15 May 2026 21:25 1 min read

PTC Therapeutics CEO Matthew B. Klein sells $917,153 in stock

PTC Therapeutics CEO Matthew B. Klein sells $917,153 in stock

PTC Therapeutics CEO Matthew B. Klein sells $917,153 in stock

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.